The chart below shows how ZYXI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ZYXI sees a -0.24% change in stock price 10 days leading up to the earnings, and a +0.39% change 10 days following the report. On the earnings day itself, the stock moves by +2.40%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
2024 Revenue Growth Projection: 1. Revenue Growth Expectation: Zynex anticipates 2024 net revenue to reach $200 million, representing a 9% increase compared to 2023, and over 50% growth from three years ago.
Order Growth Trend: 2. Order Growth: Orders increased by 13% year-over-year in Q3 2024, indicating a positive trend in demand despite a flat revenue quarter.
Sales Efficiency Improvement: 3. Increased Revenue per Sales Rep: Revenue per sales rep on an annualized basis in Q3 was $530,000, marking a 25% increase from Q3 2023, showcasing improved sales efficiency.
Cash Flow Improvement: 4. Strong Cash Position: Zynex generated $10 million in cash from operations in the first nine months of 2024, resulting in a cash balance of $37 million at the end of Q3, up from $31 million earlier in the year.
Product Portfolio Expansion: 5. Product Diversification: The NexWave private label rehab products accounted for over 31% of total orders in Q3, up from 25% in Q1, reflecting successful diversification of the product portfolio.
Negative
Device Revenue Decline: 1. Declining Device Revenue: Device revenue decreased to $14.9 million in Q3 2024 from $16.9 million in Q3 2023, indicating a significant drop due to slowing order growth.
Net Income Decline: 2. Decreased Net Income: Net income fell to $2.4 million in Q3 2024, down from $3.6 million in the same quarter last year, reflecting a decline in profitability.
Decline in Adjusted EBITDA: 3. Lower Adjusted EBITDA: Adjusted EBITDA decreased to $5.1 million in Q3 2024 compared to $7.3 million in Q3 2023, highlighting reduced operational efficiency.
Rising General and Administrative Costs: 4. Increased General and Administrative Expenses: G&A expenses rose to $15.3 million in Q3 2024 from $12.7 million in Q3 2023, primarily due to increased investments in Zynex Monitoring.
Stagnant Revenue Performance: 5. Flat Revenue Growth: Total net revenue was essentially flat at $50 million in Q3 2024 compared to $49.9 million in Q3 2023, indicating stagnation in revenue generation.
Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript
ZYXI.O
1.22%